🕵️ Pacific Biosciences of California, Inc. ($PACB)
SEC insider & ownership activity, last 12 months · CIK 1299130 · every row links its SEC filing
Over the last 12 months insiders sold $1.3M with no open-market buying against it. Christian O. Henry sold $771K in discretionary trades (Feb–Mar). No red-flag 8-Ks in the window.
Monthly net open-market insider flow, last 12 months (up = net buying)
Insider flow
0 buyers, $0 (0 lots) · 4 sellers, $1.3M (11 lots)
| Insider | Buys | Bought | Sells | Sold | Last |
|---|---|---|---|---|---|
| Christian O. Henry | 0 | – | 3 | $771K | Mar 3, 2026 |
| Mark D. Van Oene | 0 | – | 4 | $339K | Mar 3, 2026 |
| James Gibson | 0 | – | 1 | $121K | Apr 1, 2026 |
| Farmer Michele | 0 | – | 3 | $84K | Mar 3, 2026 |
5%+ holders
| Holder | Stake | Class | Schedule | Event | |
|---|---|---|---|---|---|
| ARK Investment Management LLC | 12.3% | 13G | Feb 3, 2026 | filing ↗ | |
| Catherine D. Wood | 12.3% | 13G | Feb 3, 2026 | filing ↗ | |
| Blackrock, Inc. | 7.7% | 13G | Apr 17, 2025 | filing ↗ |
Planned insider sales (Form 144)
| Seller | Planned | Approx. sale date | |
|---|---|---|---|
| James Gibson | $121K | Apr 1, 2026 | filing ↗ |
| Mark D. Van Oene | $10K | Mar 3, 2026 | filing ↗ |
| Christian Henry | $19K | Mar 3, 2026 | filing ↗ |
| Mark Van Oene | $479K | Feb 17, 2026 | filing ↗ |
| Christian Henry | $956K | Feb 17, 2026 | filing ↗ |
| Mark Van Oene | $35K | Aug 18, 2025 | filing ↗ |
Material events (8-K)
| Item | Event date | |
|---|---|---|
| Officer/director changes (5.02) | Jul 8, 2026 | filing ↗ |
| Officer/director changes (5.02) | Jun 3, 2026 | filing ↗ |
| Shareholder vote (5.07) | Jun 3, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Jun 3, 2026 | filing ↗ |
| Earnings (2.02) | May 7, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | May 7, 2026 | filing ↗ |
| Officer/director changes (5.02) | Mar 3, 2026 | filing ↗ |
| Reg FD disclosure (7.01) | Mar 3, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Mar 3, 2026 | filing ↗ |
| Officer/director changes (5.02) | Mar 2, 2026 | filing ↗ |
| Reg FD disclosure (7.01) | Mar 2, 2026 | filing ↗ |
| Earnings (2.02) | Feb 12, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Feb 12, 2026 | filing ↗ |
| Material agreement (1.01) | Jan 30, 2026 | filing ↗ |
| Acquisition or disposition (2.01) | Jan 30, 2026 | filing ↗ |
| Reg FD disclosure (7.01) | Jan 30, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Jan 30, 2026 | filing ↗ |
| Officer/director changes (5.02) | Jan 28, 2026 | filing ↗ |
| Earnings (2.02) | Jan 12, 2026 | filing ↗ |
| Other events (8.01) | Jan 12, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Jan 12, 2026 | filing ↗ |
| Earnings (2.02) | Nov 5, 2025 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Nov 5, 2025 | filing ↗ |
| Earnings (2.02) | Aug 7, 2025 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Aug 7, 2025 | filing ↗ |